nodes	percent_of_prediction	percent_of_DWPC	metapath
Estrone—prostate cancer—urinary bladder cancer	0.447	1	CtDrD
Estrone—ESR2—urinary bladder cancer	0.153	0.619	CbGaD
Estrone—ESR1—urinary bladder cancer	0.0944	0.381	CbGaD
Estrone—CYP4A11—Cisplatin—urinary bladder cancer	0.042	0.193	CbGbCtD
Estrone—CYP2B6—Thiotepa—urinary bladder cancer	0.0211	0.097	CbGbCtD
Estrone—ABCB1—Mitomycin—urinary bladder cancer	0.0143	0.0656	CbGbCtD
Estrone—CYP1B1—Doxorubicin—urinary bladder cancer	0.0117	0.0536	CbGbCtD
Estrone—ABCG2—Fluorouracil—urinary bladder cancer	0.00977	0.0448	CbGbCtD
Estrone—ABCG2—Carboplatin—urinary bladder cancer	0.00971	0.0445	CbGbCtD
Estrone—ABCG2—Cisplatin—urinary bladder cancer	0.0083	0.0381	CbGbCtD
Estrone—ABCG2—Etoposide—urinary bladder cancer	0.00815	0.0374	CbGbCtD
Estrone—SLCO1A2—Methotrexate—urinary bladder cancer	0.00719	0.033	CbGbCtD
Estrone—SLCO1B1—Methotrexate—urinary bladder cancer	0.00678	0.0311	CbGbCtD
Estrone—ALB—Fluorouracil—urinary bladder cancer	0.00673	0.0309	CbGbCtD
Estrone—CYP3A4—Thiotepa—urinary bladder cancer	0.00649	0.0298	CbGbCtD
Estrone—CYP2B6—Cisplatin—urinary bladder cancer	0.00583	0.0268	CbGbCtD
Estrone—CYP2E1—Etoposide—urinary bladder cancer	0.00581	0.0267	CbGbCtD
Estrone—ABCG2—Doxorubicin—urinary bladder cancer	0.00556	0.0255	CbGbCtD
Estrone—ABCG2—Methotrexate—urinary bladder cancer	0.00539	0.0247	CbGbCtD
Estrone—CYP3A5—Etoposide—urinary bladder cancer	0.00452	0.0207	CbGbCtD
Estrone—ABCB1—Gemcitabine—urinary bladder cancer	0.00412	0.0189	CbGbCtD
Estrone—CYP1A2—Fluorouracil—urinary bladder cancer	0.00403	0.0185	CbGbCtD
Estrone—CYP2B6—Doxorubicin—urinary bladder cancer	0.00391	0.0179	CbGbCtD
Estrone—ALB—Methotrexate—urinary bladder cancer	0.00371	0.017	CbGbCtD
Estrone—CYP2C9—Fluorouracil—urinary bladder cancer	0.00363	0.0166	CbGbCtD
Estrone—CYP1A2—Etoposide—urinary bladder cancer	0.00336	0.0154	CbGbCtD
Estrone—CYP2C9—Cisplatin—urinary bladder cancer	0.00308	0.0141	CbGbCtD
Estrone—ABCB1—Cisplatin—urinary bladder cancer	0.00299	0.0137	CbGbCtD
Estrone—ABCB1—Etoposide—urinary bladder cancer	0.00294	0.0135	CbGbCtD
Estrone—ABCB1—Doxorubicin—urinary bladder cancer	0.002	0.00919	CbGbCtD
Estrone—ABCB1—Methotrexate—urinary bladder cancer	0.00194	0.00891	CbGbCtD
Estrone—CYP3A4—Etoposide—urinary bladder cancer	0.00176	0.00808	CbGbCtD
Estrone—CYP3A4—Doxorubicin—urinary bladder cancer	0.0012	0.00551	CbGbCtD
Estrone—CYP4A11—renal system—urinary bladder cancer	0.000929	0.0459	CbGeAlD
Estrone—CYP1A2—urine—urinary bladder cancer	0.000873	0.0432	CbGeAlD
Estrone—CYP2C9—urine—urinary bladder cancer	0.000829	0.041	CbGeAlD
Estrone—CYP2E1—urine—urinary bladder cancer	0.000786	0.0388	CbGeAlD
Estrone—CYP4A11—vagina—urinary bladder cancer	0.000673	0.0333	CbGeAlD
Estrone—CYP3A4—urine—urinary bladder cancer	0.000632	0.0313	CbGeAlD
Estrone—Breast cancer—Gemcitabine—urinary bladder cancer	0.000621	0.0309	CcSEcCtD
Estrone—ESR2—prostate gland—urinary bladder cancer	0.000594	0.0294	CbGeAlD
Estrone—Mood alteration NOS—Methotrexate—urinary bladder cancer	0.000578	0.0288	CcSEcCtD
Estrone—SHBG—prostate gland—urinary bladder cancer	0.000577	0.0285	CbGeAlD
Estrone—Irritability—Valrubicin—urinary bladder cancer	0.000539	0.0268	CcSEcCtD
Estrone—SLCO2B1—prostate gland—urinary bladder cancer	0.000521	0.0258	CbGeAlD
Estrone—Thrombophlebitis—Mitomycin—urinary bladder cancer	0.000449	0.0224	CcSEcCtD
Estrone—CYP1B1—prostate gland—urinary bladder cancer	0.000437	0.0216	CbGeAlD
Estrone—ESR2—epithelium—urinary bladder cancer	0.000436	0.0216	CbGeAlD
Estrone—ESR2—smooth muscle tissue—urinary bladder cancer	0.00042	0.0208	CbGeAlD
Estrone—ESR1—prostate gland—urinary bladder cancer	0.000407	0.0201	CbGeAlD
Estrone—ESR2—renal system—urinary bladder cancer	0.000405	0.02	CbGeAlD
Estrone—SLCO1B1—renal system—urinary bladder cancer	0.000402	0.0199	CbGeAlD
Estrone—Vaginal haemorrhage—Thiotepa—urinary bladder cancer	0.000364	0.0181	CcSEcCtD
Estrone—SLCO2B1—renal system—urinary bladder cancer	0.000355	0.0176	CbGeAlD
Estrone—Flatulence—Valrubicin—urinary bladder cancer	0.000335	0.0167	CcSEcCtD
Estrone—SLCO1A2—renal system—urinary bladder cancer	0.000327	0.0162	CbGeAlD
Estrone—ABCG2—prostate gland—urinary bladder cancer	0.000326	0.0161	CbGeAlD
Estrone—ESR2—female reproductive system—urinary bladder cancer	0.000324	0.016	CbGeAlD
Estrone—SLCO1B1—female reproductive system—urinary bladder cancer	0.000322	0.0159	CbGeAlD
Estrone—SHBG—female reproductive system—urinary bladder cancer	0.000315	0.0156	CbGeAlD
Estrone—CYP1B1—smooth muscle tissue—urinary bladder cancer	0.00031	0.0153	CbGeAlD
Estrone—CYP3A5—prostate gland—urinary bladder cancer	0.000302	0.015	CbGeAlD
Estrone—ESR1—epithelium—urinary bladder cancer	0.000299	0.0148	CbGeAlD
Estrone—CYP1B1—renal system—urinary bladder cancer	0.000298	0.0147	CbGeAlD
Estrone—ESR2—vagina—urinary bladder cancer	0.000293	0.0145	CbGeAlD
Estrone—Estriol—ESR2—urinary bladder cancer	0.000289	0.122	CrCbGaD
Estrone—ESR1—smooth muscle tissue—urinary bladder cancer	0.000288	0.0142	CbGeAlD
Estrone—SHBG—vagina—urinary bladder cancer	0.000285	0.0141	CbGeAlD
Estrone—SLCO2B1—female reproductive system—urinary bladder cancer	0.000284	0.0141	CbGeAlD
Estrone—Dementia—Methotrexate—urinary bladder cancer	0.000283	0.0141	CcSEcCtD
Estrone—CYP2E1—prostate gland—urinary bladder cancer	0.000282	0.0139	CbGeAlD
Estrone—ESR1—renal system—urinary bladder cancer	0.000277	0.0137	CbGeAlD
Estrone—ABCG2—seminal vesicle—urinary bladder cancer	0.000276	0.0136	CbGeAlD
Estrone—Quinestrol—ESR1—urinary bladder cancer	0.000269	0.113	CrCbGaD
Estrone—Estramustine—ESR2—urinary bladder cancer	0.000269	0.113	CrCbGaD
Estrone—Tenderness—Gemcitabine—urinary bladder cancer	0.00026	0.0129	CcSEcCtD
Estrone—Tenderness—Fluorouracil—urinary bladder cancer	0.000256	0.0127	CcSEcCtD
Estrone—Musculoskeletal discomfort—Valrubicin—urinary bladder cancer	0.000253	0.0126	CcSEcCtD
Estrone—Erythema nodosum—Epirubicin—urinary bladder cancer	0.000251	0.0125	CcSEcCtD
Estrone—Hypocalcaemia—Gemcitabine—urinary bladder cancer	0.000248	0.0123	CcSEcCtD
Estrone—Tenderness—Cisplatin—urinary bladder cancer	0.000242	0.0121	CcSEcCtD
Estrone—CYP1B1—female reproductive system—urinary bladder cancer	0.000239	0.0118	CbGeAlD
Estrone—CYP2E1—seminal vesicle—urinary bladder cancer	0.000239	0.0118	CbGeAlD
Estrone—Erythema nodosum—Doxorubicin—urinary bladder cancer	0.000232	0.0116	CcSEcCtD
Estrone—CYP1A1—epithelium—urinary bladder cancer	0.000227	0.0112	CbGeAlD
Estrone—ESR1—female reproductive system—urinary bladder cancer	0.000222	0.011	CbGeAlD
Estrone—Estropipate—ESR2—urinary bladder cancer	0.000221	0.093	CrCbGaD
Estrone—Pain—Carboplatin—urinary bladder cancer	0.00022	0.0109	CcSEcCtD
Estrone—Abdominal pain—Valrubicin—urinary bladder cancer	0.000219	0.0109	CcSEcCtD
Estrone—ABCG2—urethra—urinary bladder cancer	0.000218	0.0108	CbGeAlD
Estrone—Vaginal moniliasis—Epirubicin—urinary bladder cancer	0.000215	0.0107	CcSEcCtD
Estrone—CYP1A2—renal system—urinary bladder cancer	0.000214	0.0106	CbGeAlD
Estrone—CYP1A1—renal system—urinary bladder cancer	0.000211	0.0104	CbGeAlD
Estrone—CYP1A1—urethra—urinary bladder cancer	0.000207	0.0102	CbGeAlD
Estrone—Vulvovaginal candidiasis—Epirubicin—urinary bladder cancer	0.000206	0.0103	CcSEcCtD
Estrone—CYP3A5—renal system—urinary bladder cancer	0.000206	0.0102	CbGeAlD
Estrone—CYP2B6—renal system—urinary bladder cancer	0.000205	0.0101	CbGeAlD
Estrone—Mestranol—ESR1—urinary bladder cancer	0.000204	0.0858	CrCbGaD
Estrone—ESR1—vagina—urinary bladder cancer	0.000201	0.00993	CbGeAlD
Estrone—Vaginal moniliasis—Doxorubicin—urinary bladder cancer	0.000199	0.00991	CcSEcCtD
Estrone—Vulvovaginal mycotic infection—Epirubicin—urinary bladder cancer	0.000199	0.00988	CcSEcCtD
Estrone—Pruritus—Valrubicin—urinary bladder cancer	0.000196	0.00978	CcSEcCtD
Estrone—CYP2E1—renal system—urinary bladder cancer	0.000192	0.0095	CbGeAlD
Estrone—Oedema—Mitomycin—urinary bladder cancer	0.000191	0.00952	CcSEcCtD
Estrone—Vulvovaginal candidiasis—Doxorubicin—urinary bladder cancer	0.000191	0.00951	CcSEcCtD
Estrone—ESR2—lymph node—urinary bladder cancer	0.00019	0.00938	CbGeAlD
Estrone—CYP2E1—urethra—urinary bladder cancer	0.000189	0.00934	CbGeAlD
Estrone—Thrombophlebitis—Fluorouracil—urinary bladder cancer	0.000187	0.00931	CcSEcCtD
Estrone—Vulvovaginal mycotic infection—Doxorubicin—urinary bladder cancer	0.000184	0.00915	CcSEcCtD
Estrone—Dizziness—Valrubicin—urinary bladder cancer	0.000184	0.00914	CcSEcCtD
Estrone—Estriol—ESR1—urinary bladder cancer	0.000178	0.0749	CrCbGaD
Estrone—Vomiting—Valrubicin—urinary bladder cancer	0.000176	0.00879	CcSEcCtD
Estrone—Rash—Valrubicin—urinary bladder cancer	0.000175	0.00871	CcSEcCtD
Estrone—Dermatitis—Valrubicin—urinary bladder cancer	0.000175	0.00871	CcSEcCtD
Estrone—Headache—Valrubicin—urinary bladder cancer	0.000174	0.00866	CcSEcCtD
Estrone—CYP1A1—female reproductive system—urinary bladder cancer	0.000169	0.00835	CbGeAlD
Estrone—Cerebrovascular accident—Gemcitabine—urinary bladder cancer	0.000168	0.00836	CcSEcCtD
Estrone—SLCO2B1—lymph node—urinary bladder cancer	0.000166	0.00823	CbGeAlD
Estrone—Estramustine—ESR1—urinary bladder cancer	0.000166	0.0696	CrCbGaD
Estrone—Nausea—Valrubicin—urinary bladder cancer	0.000165	0.00821	CcSEcCtD
Estrone—CYP2B6—female reproductive system—urinary bladder cancer	0.000164	0.00811	CbGeAlD
Estrone—Pain—Mitomycin—urinary bladder cancer	0.000164	0.00814	CcSEcCtD
Estrone—CYP2C9—female reproductive system—urinary bladder cancer	0.000162	0.00803	CbGeAlD
Estrone—ABCG2—vagina—urinary bladder cancer	0.000161	0.00795	CbGeAlD
Estrone—ABCB1—prostate gland—urinary bladder cancer	0.000161	0.00794	CbGeAlD
Estrone—Ethinyl Estradiol—ESR2—urinary bladder cancer	0.000158	0.0664	CrCbGaD
Estrone—Cerebrovascular accident—Cisplatin—urinary bladder cancer	0.000157	0.0078	CcSEcCtD
Estrone—CYP3A4—renal system—urinary bladder cancer	0.000155	0.00765	CbGeAlD
Estrone—Irritability—Fluorouracil—urinary bladder cancer	0.000154	0.00769	CcSEcCtD
Estrone—CYP2E1—female reproductive system—urinary bladder cancer	0.000154	0.00761	CbGeAlD
Estrone—CYP1A1—vagina—urinary bladder cancer	0.000153	0.00755	CbGeAlD
Estrone—ALB—lymph node—urinary bladder cancer	0.000152	0.00753	CbGeAlD
Estrone—CYP3A5—vagina—urinary bladder cancer	0.000149	0.00738	CbGeAlD
Estrone—CYP2B6—vagina—urinary bladder cancer	0.000148	0.00734	CbGeAlD
Estrone—Vaginal haemorrhage—Epirubicin—urinary bladder cancer	0.000147	0.0073	CcSEcCtD
Estrone—Irritability—Cisplatin—urinary bladder cancer	0.000146	0.00729	CcSEcCtD
Estrone—CYP1B1—lymph node—urinary bladder cancer	0.00014	0.00691	CbGeAlD
Estrone—Conjugated Estrogens—ESR2—urinary bladder cancer	0.000138	0.058	CrCbGaD
Estrone—Estropipate—ESR1—urinary bladder cancer	0.000136	0.0573	CrCbGaD
Estrone—ABCB1—seminal vesicle—urinary bladder cancer	0.000136	0.00672	CbGeAlD
Estrone—Vaginal haemorrhage—Doxorubicin—urinary bladder cancer	0.000136	0.00676	CcSEcCtD
Estrone—Pancreatitis—Cisplatin—urinary bladder cancer	0.00013	0.00647	CcSEcCtD
Estrone—ESR1—lymph node—urinary bladder cancer	0.00013	0.00642	CbGeAlD
Estrone—Dizziness—Mitomycin—urinary bladder cancer	0.000126	0.0063	CcSEcCtD
Estrone—Acute coronary syndrome—Gemcitabine—urinary bladder cancer	0.000125	0.00623	CcSEcCtD
Estrone—Myocardial infarction—Gemcitabine—urinary bladder cancer	0.000124	0.00619	CcSEcCtD
Estrone—CYP3A4—female reproductive system—urinary bladder cancer	0.000124	0.00612	CbGeAlD
Estrone—Jaundice cholestatic—Epirubicin—urinary bladder cancer	0.000124	0.00615	CcSEcCtD
Estrone—Acute coronary syndrome—Fluorouracil—urinary bladder cancer	0.000123	0.00612	CcSEcCtD
Estrone—Myocardial infarction—Fluorouracil—urinary bladder cancer	0.000122	0.00609	CcSEcCtD
Estrone—Vomiting—Mitomycin—urinary bladder cancer	0.000122	0.00605	CcSEcCtD
Estrone—Rash—Mitomycin—urinary bladder cancer	0.000121	0.006	CcSEcCtD
Estrone—Dermatitis—Mitomycin—urinary bladder cancer	0.00012	0.006	CcSEcCtD
Estrone—Headache—Mitomycin—urinary bladder cancer	0.00012	0.00596	CcSEcCtD
Estrone—Hypocalcaemia—Epirubicin—urinary bladder cancer	0.000119	0.0059	CcSEcCtD
Estrone—ABCB1—epithelium—urinary bladder cancer	0.000118	0.00584	CbGeAlD
Estrone—Acute coronary syndrome—Cisplatin—urinary bladder cancer	0.000117	0.0058	CcSEcCtD
Estrone—Pulmonary embolism—Methotrexate—urinary bladder cancer	0.000116	0.00577	CcSEcCtD
Estrone—Vaginal inflammation—Methotrexate—urinary bladder cancer	0.000116	0.00577	CcSEcCtD
Estrone—Myocardial infarction—Cisplatin—urinary bladder cancer	0.000116	0.00577	CcSEcCtD
Estrone—Tension—Thiotepa—urinary bladder cancer	0.000116	0.00576	CcSEcCtD
Estrone—Nervousness—Thiotepa—urinary bladder cancer	0.000114	0.0057	CcSEcCtD
Estrone—Jaundice cholestatic—Doxorubicin—urinary bladder cancer	0.000114	0.00569	CcSEcCtD
Estrone—Nausea—Mitomycin—urinary bladder cancer	0.000114	0.00566	CcSEcCtD
Estrone—Hypocalcaemia—Doxorubicin—urinary bladder cancer	0.00011	0.00546	CcSEcCtD
Estrone—Vaginal infection—Methotrexate—urinary bladder cancer	0.000109	0.00545	CcSEcCtD
Estrone—ABCB1—renal system—urinary bladder cancer	0.000109	0.00541	CbGeAlD
Estrone—Vaginal inflammation—Epirubicin—urinary bladder cancer	0.000109	0.0054	CcSEcCtD
Estrone—Pulmonary embolism—Epirubicin—urinary bladder cancer	0.000109	0.0054	CcSEcCtD
Estrone—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.000108	0.00536	CcSEcCtD
Estrone—ABCB1—urethra—urinary bladder cancer	0.000108	0.00532	CbGeAlD
Estrone—Acute coronary syndrome—Etoposide—urinary bladder cancer	0.000107	0.00532	CcSEcCtD
Estrone—Myocardial infarction—Etoposide—urinary bladder cancer	0.000106	0.00529	CcSEcCtD
Estrone—Estradiol—ESR2—urinary bladder cancer	0.000104	0.0438	CrCbGaD
Estrone—ABCG2—lymph node—urinary bladder cancer	0.000104	0.00514	CbGeAlD
Estrone—Vaginal infection—Epirubicin—urinary bladder cancer	0.000102	0.0051	CcSEcCtD
Estrone—Pulmonary embolism—Doxorubicin—urinary bladder cancer	0.0001	0.005	CcSEcCtD
Estrone—Vaginal inflammation—Doxorubicin—urinary bladder cancer	0.0001	0.005	CcSEcCtD
Estrone—Arthralgia—Thiotepa—urinary bladder cancer	0.0001	0.005	CcSEcCtD
Estrone—Cramps of lower extremities—Epirubicin—urinary bladder cancer	9.97e-05	0.00496	CcSEcCtD
Estrone—CYP1A1—lymph node—urinary bladder cancer	9.88e-05	0.00488	CbGeAlD
Estrone—Ethinyl Estradiol—ESR1—urinary bladder cancer	9.73e-05	0.0409	CrCbGaD
Estrone—Thrombophlebitis—Methotrexate—urinary bladder cancer	9.73e-05	0.00484	CcSEcCtD
Estrone—Vaginal infection—Doxorubicin—urinary bladder cancer	9.48e-05	0.00472	CcSEcCtD
Estrone—Cramps of lower extremities—Doxorubicin—urinary bladder cancer	9.23e-05	0.00459	CcSEcCtD
Estrone—Erythema multiforme—Etoposide—urinary bladder cancer	9.19e-05	0.00458	CcSEcCtD
Estrone—Flatulence—Cisplatin—urinary bladder cancer	9.1e-05	0.00453	CcSEcCtD
Estrone—Thrombophlebitis—Epirubicin—urinary bladder cancer	9.1e-05	0.00453	CcSEcCtD
Estrone—Muscle spasms—Cisplatin—urinary bladder cancer	8.88e-05	0.00442	CcSEcCtD
Estrone—ABCB1—female reproductive system—urinary bladder cancer	8.77e-05	0.00434	CbGeAlD
Estrone—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	8.76e-05	0.00436	CcSEcCtD
Estrone—Cerebrovascular accident—Methotrexate—urinary bladder cancer	8.59e-05	0.00428	CcSEcCtD
Estrone—Conjugated Estrogens—ESR1—urinary bladder cancer	8.5e-05	0.0357	CrCbGaD
Estrone—Arthralgia—Gemcitabine—urinary bladder cancer	8.44e-05	0.0042	CcSEcCtD
Estrone—Thrombophlebitis—Doxorubicin—urinary bladder cancer	8.42e-05	0.00419	CcSEcCtD
Estrone—Pain—Thiotepa—urinary bladder cancer	8.22e-05	0.00409	CcSEcCtD
Estrone—Purpura—Epirubicin—urinary bladder cancer	8.17e-05	0.00407	CcSEcCtD
Estrone—Muscle spasms—Etoposide—urinary bladder cancer	8.14e-05	0.00405	CcSEcCtD
Estrone—Oedema—Gemcitabine—urinary bladder cancer	8.09e-05	0.00403	CcSEcCtD
Estrone—Anaphylactic shock—Gemcitabine—urinary bladder cancer	8.09e-05	0.00403	CcSEcCtD
Estrone—Cerebrovascular accident—Epirubicin—urinary bladder cancer	8.04e-05	0.004	CcSEcCtD
Estrone—Irritability—Methotrexate—urinary bladder cancer	8.04e-05	0.004	CcSEcCtD
Estrone—Mood swings—Methotrexate—urinary bladder cancer	7.98e-05	0.00397	CcSEcCtD
Estrone—Oedema—Fluorouracil—urinary bladder cancer	7.95e-05	0.00396	CcSEcCtD
Estrone—Anaphylactic shock—Fluorouracil—urinary bladder cancer	7.95e-05	0.00396	CcSEcCtD
Estrone—ABCB1—vagina—urinary bladder cancer	7.93e-05	0.00392	CbGeAlD
Estrone—Migraine—Epirubicin—urinary bladder cancer	7.76e-05	0.00386	CcSEcCtD
Estrone—Urticaria—Thiotepa—urinary bladder cancer	7.64e-05	0.0038	CcSEcCtD
Estrone—Abdominal pain—Thiotepa—urinary bladder cancer	7.6e-05	0.00379	CcSEcCtD
Estrone—Purpura—Doxorubicin—urinary bladder cancer	7.56e-05	0.00377	CcSEcCtD
Estrone—Oedema—Cisplatin—urinary bladder cancer	7.54e-05	0.00375	CcSEcCtD
Estrone—Anaphylactic shock—Cisplatin—urinary bladder cancer	7.54e-05	0.00375	CcSEcCtD
Estrone—Mood swings—Epirubicin—urinary bladder cancer	7.46e-05	0.00372	CcSEcCtD
Estrone—Cerebrovascular accident—Doxorubicin—urinary bladder cancer	7.44e-05	0.0037	CcSEcCtD
Estrone—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	7.37e-05	0.00367	CcSEcCtD
Estrone—Asthma—Methotrexate—urinary bladder cancer	7.28e-05	0.00362	CcSEcCtD
Estrone—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	7.25e-05	0.00361	CcSEcCtD
Estrone—Migraine—Doxorubicin—urinary bladder cancer	7.18e-05	0.00357	CcSEcCtD
Estrone—Pancreatitis—Methotrexate—urinary bladder cancer	7.13e-05	0.00355	CcSEcCtD
Estrone—Pain—Gemcitabine—urinary bladder cancer	6.92e-05	0.00344	CcSEcCtD
Estrone—Anaphylactic shock—Etoposide—urinary bladder cancer	6.91e-05	0.00344	CcSEcCtD
Estrone—Mood swings—Doxorubicin—urinary bladder cancer	6.91e-05	0.00344	CcSEcCtD
Estrone—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	6.87e-05	0.00342	CcSEcCtD
Estrone—Abdominal distension—Epirubicin—urinary bladder cancer	6.86e-05	0.00341	CcSEcCtD
Estrone—Asthma—Epirubicin—urinary bladder cancer	6.81e-05	0.00339	CcSEcCtD
Estrone—Pruritus—Thiotepa—urinary bladder cancer	6.8e-05	0.00339	CcSEcCtD
Estrone—Pain—Fluorouracil—urinary bladder cancer	6.8e-05	0.00339	CcSEcCtD
Estrone—Pancreatitis—Epirubicin—urinary bladder cancer	6.68e-05	0.00332	CcSEcCtD
Estrone—Depression—Methotrexate—urinary bladder cancer	6.47e-05	0.00322	CcSEcCtD
Estrone—Pain—Cisplatin—urinary bladder cancer	6.45e-05	0.00321	CcSEcCtD
Estrone—Estradiol—ESR1—urinary bladder cancer	6.42e-05	0.027	CrCbGaD
Estrone—Dizziness—Thiotepa—urinary bladder cancer	6.36e-05	0.00317	CcSEcCtD
Estrone—Abdominal distension—Doxorubicin—urinary bladder cancer	6.34e-05	0.00316	CcSEcCtD
Estrone—Urticaria—Fluorouracil—urinary bladder cancer	6.32e-05	0.00315	CcSEcCtD
Estrone—Asthma—Doxorubicin—urinary bladder cancer	6.3e-05	0.00314	CcSEcCtD
Estrone—Pancreatitis—Doxorubicin—urinary bladder cancer	6.18e-05	0.00308	CcSEcCtD
Estrone—Vomiting—Thiotepa—urinary bladder cancer	6.11e-05	0.00304	CcSEcCtD
Estrone—Rash—Thiotepa—urinary bladder cancer	6.06e-05	0.00302	CcSEcCtD
Estrone—Dermatitis—Thiotepa—urinary bladder cancer	6.06e-05	0.00302	CcSEcCtD
Estrone—Headache—Thiotepa—urinary bladder cancer	6.02e-05	0.003	CcSEcCtD
Estrone—Pain—Etoposide—urinary bladder cancer	5.91e-05	0.00294	CcSEcCtD
Estrone—Pruritus—Gemcitabine—urinary bladder cancer	5.72e-05	0.00285	CcSEcCtD
Estrone—Nausea—Thiotepa—urinary bladder cancer	5.71e-05	0.00284	CcSEcCtD
Estrone—Pruritus—Fluorouracil—urinary bladder cancer	5.63e-05	0.0028	CcSEcCtD
Estrone—Erythema multiforme—Methotrexate—urinary bladder cancer	5.51e-05	0.00274	CcSEcCtD
Estrone—Urticaria—Etoposide—urinary bladder cancer	5.49e-05	0.00273	CcSEcCtD
Estrone—Abdominal pain—Etoposide—urinary bladder cancer	5.46e-05	0.00272	CcSEcCtD
Estrone—Dizziness—Fluorouracil—urinary bladder cancer	5.26e-05	0.00262	CcSEcCtD
Estrone—Erythema multiforme—Epirubicin—urinary bladder cancer	5.15e-05	0.00257	CcSEcCtD
Estrone—Vomiting—Gemcitabine—urinary bladder cancer	5.14e-05	0.00256	CcSEcCtD
Estrone—ABCB1—lymph node—urinary bladder cancer	5.13e-05	0.00254	CbGeAlD
Estrone—Rash—Gemcitabine—urinary bladder cancer	5.1e-05	0.00254	CcSEcCtD
Estrone—Dermatitis—Gemcitabine—urinary bladder cancer	5.1e-05	0.00254	CcSEcCtD
Estrone—Headache—Gemcitabine—urinary bladder cancer	5.07e-05	0.00252	CcSEcCtD
Estrone—Vomiting—Fluorouracil—urinary bladder cancer	5.06e-05	0.00252	CcSEcCtD
Estrone—Rash—Fluorouracil—urinary bladder cancer	5.02e-05	0.0025	CcSEcCtD
Estrone—Dermatitis—Fluorouracil—urinary bladder cancer	5.01e-05	0.00249	CcSEcCtD
Estrone—Headache—Fluorouracil—urinary bladder cancer	4.98e-05	0.00248	CcSEcCtD
Estrone—Pruritus—Etoposide—urinary bladder cancer	4.89e-05	0.00243	CcSEcCtD
Estrone—Nausea—Gemcitabine—urinary bladder cancer	4.81e-05	0.00239	CcSEcCtD
Estrone—Vomiting—Cisplatin—urinary bladder cancer	4.79e-05	0.00239	CcSEcCtD
Estrone—Erythema multiforme—Doxorubicin—urinary bladder cancer	4.77e-05	0.00237	CcSEcCtD
Estrone—Rash—Cisplatin—urinary bladder cancer	4.75e-05	0.00237	CcSEcCtD
Estrone—Dermatitis—Cisplatin—urinary bladder cancer	4.75e-05	0.00237	CcSEcCtD
Estrone—Nausea—Fluorouracil—urinary bladder cancer	4.72e-05	0.00235	CcSEcCtD
Estrone—Flatulence—Epirubicin—urinary bladder cancer	4.68e-05	0.00233	CcSEcCtD
Estrone—Tension—Epirubicin—urinary bladder cancer	4.66e-05	0.00232	CcSEcCtD
Estrone—Nervousness—Epirubicin—urinary bladder cancer	4.61e-05	0.00229	CcSEcCtD
Estrone—Dizziness—Etoposide—urinary bladder cancer	4.57e-05	0.00227	CcSEcCtD
Estrone—Muscle spasms—Epirubicin—urinary bladder cancer	4.56e-05	0.00227	CcSEcCtD
Estrone—Nausea—Cisplatin—urinary bladder cancer	4.48e-05	0.00223	CcSEcCtD
Estrone—Vomiting—Etoposide—urinary bladder cancer	4.39e-05	0.00219	CcSEcCtD
Estrone—Rash—Etoposide—urinary bladder cancer	4.36e-05	0.00217	CcSEcCtD
Estrone—Dermatitis—Etoposide—urinary bladder cancer	4.35e-05	0.00217	CcSEcCtD
Estrone—Headache—Etoposide—urinary bladder cancer	4.33e-05	0.00215	CcSEcCtD
Estrone—Flatulence—Doxorubicin—urinary bladder cancer	4.33e-05	0.00215	CcSEcCtD
Estrone—Arthralgia—Methotrexate—urinary bladder cancer	4.32e-05	0.00215	CcSEcCtD
Estrone—Tension—Doxorubicin—urinary bladder cancer	4.31e-05	0.00215	CcSEcCtD
Estrone—Nervousness—Doxorubicin—urinary bladder cancer	4.26e-05	0.00212	CcSEcCtD
Estrone—Muscle spasms—Doxorubicin—urinary bladder cancer	4.22e-05	0.0021	CcSEcCtD
Estrone—Anaphylactic shock—Methotrexate—urinary bladder cancer	4.14e-05	0.00206	CcSEcCtD
Estrone—Nausea—Etoposide—urinary bladder cancer	4.1e-05	0.00204	CcSEcCtD
Estrone—Arthralgia—Epirubicin—urinary bladder cancer	4.04e-05	0.00201	CcSEcCtD
Estrone—Anaphylactic shock—Epirubicin—urinary bladder cancer	3.87e-05	0.00193	CcSEcCtD
Estrone—Oedema—Epirubicin—urinary bladder cancer	3.87e-05	0.00193	CcSEcCtD
Estrone—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	3.77e-05	0.00188	CcSEcCtD
Estrone—Arthralgia—Doxorubicin—urinary bladder cancer	3.74e-05	0.00186	CcSEcCtD
Estrone—Anaphylactic shock—Doxorubicin—urinary bladder cancer	3.58e-05	0.00178	CcSEcCtD
Estrone—Oedema—Doxorubicin—urinary bladder cancer	3.58e-05	0.00178	CcSEcCtD
Estrone—Pain—Methotrexate—urinary bladder cancer	3.54e-05	0.00176	CcSEcCtD
Estrone—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	3.53e-05	0.00176	CcSEcCtD
Estrone—Pain—Epirubicin—urinary bladder cancer	3.31e-05	0.00165	CcSEcCtD
Estrone—Urticaria—Methotrexate—urinary bladder cancer	3.29e-05	0.00164	CcSEcCtD
Estrone—Abdominal pain—Methotrexate—urinary bladder cancer	3.27e-05	0.00163	CcSEcCtD
Estrone—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	3.26e-05	0.00163	CcSEcCtD
Estrone—Urticaria—Epirubicin—urinary bladder cancer	3.08e-05	0.00153	CcSEcCtD
Estrone—Pain—Doxorubicin—urinary bladder cancer	3.06e-05	0.00153	CcSEcCtD
Estrone—Abdominal pain—Epirubicin—urinary bladder cancer	3.06e-05	0.00152	CcSEcCtD
Estrone—Pruritus—Methotrexate—urinary bladder cancer	2.93e-05	0.00146	CcSEcCtD
Estrone—Urticaria—Doxorubicin—urinary bladder cancer	2.85e-05	0.00142	CcSEcCtD
Estrone—Abdominal pain—Doxorubicin—urinary bladder cancer	2.83e-05	0.00141	CcSEcCtD
Estrone—Pruritus—Epirubicin—urinary bladder cancer	2.74e-05	0.00136	CcSEcCtD
Estrone—Dizziness—Methotrexate—urinary bladder cancer	2.74e-05	0.00136	CcSEcCtD
Estrone—Vomiting—Methotrexate—urinary bladder cancer	2.63e-05	0.00131	CcSEcCtD
Estrone—Rash—Methotrexate—urinary bladder cancer	2.61e-05	0.0013	CcSEcCtD
Estrone—Dermatitis—Methotrexate—urinary bladder cancer	2.61e-05	0.0013	CcSEcCtD
Estrone—Headache—Methotrexate—urinary bladder cancer	2.59e-05	0.00129	CcSEcCtD
Estrone—Dizziness—Epirubicin—urinary bladder cancer	2.56e-05	0.00127	CcSEcCtD
Estrone—Pruritus—Doxorubicin—urinary bladder cancer	2.53e-05	0.00126	CcSEcCtD
Estrone—Vomiting—Epirubicin—urinary bladder cancer	2.46e-05	0.00123	CcSEcCtD
Estrone—Nausea—Methotrexate—urinary bladder cancer	2.46e-05	0.00122	CcSEcCtD
Estrone—Rash—Epirubicin—urinary bladder cancer	2.44e-05	0.00122	CcSEcCtD
Estrone—Dermatitis—Epirubicin—urinary bladder cancer	2.44e-05	0.00121	CcSEcCtD
Estrone—Headache—Epirubicin—urinary bladder cancer	2.43e-05	0.00121	CcSEcCtD
Estrone—Dizziness—Doxorubicin—urinary bladder cancer	2.37e-05	0.00118	CcSEcCtD
Estrone—Nausea—Epirubicin—urinary bladder cancer	2.3e-05	0.00115	CcSEcCtD
Estrone—Vomiting—Doxorubicin—urinary bladder cancer	2.28e-05	0.00113	CcSEcCtD
Estrone—Rash—Doxorubicin—urinary bladder cancer	2.26e-05	0.00112	CcSEcCtD
Estrone—Dermatitis—Doxorubicin—urinary bladder cancer	2.26e-05	0.00112	CcSEcCtD
Estrone—Headache—Doxorubicin—urinary bladder cancer	2.24e-05	0.00112	CcSEcCtD
Estrone—Nausea—Doxorubicin—urinary bladder cancer	2.13e-05	0.00106	CcSEcCtD
Estrone—CYP1B1—Metabolism—GSTM1—urinary bladder cancer	4.46e-06	9.9e-05	CbGpPWpGaD
Estrone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	4.46e-06	9.88e-05	CbGpPWpGaD
Estrone—CYP1A1—Metabolism—HPGDS—urinary bladder cancer	4.45e-06	9.87e-05	CbGpPWpGaD
Estrone—CYP1A1—Metabolism—ENO2—urinary bladder cancer	4.45e-06	9.87e-05	CbGpPWpGaD
Estrone—ABCB1—Metabolism—NAT2—urinary bladder cancer	4.45e-06	9.86e-05	CbGpPWpGaD
Estrone—SLCO1B1—Metabolism—TYMS—urinary bladder cancer	4.44e-06	9.84e-05	CbGpPWpGaD
Estrone—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.42e-06	9.81e-05	CbGpPWpGaD
Estrone—ABCG2—Metabolism—GSTP1—urinary bladder cancer	4.42e-06	9.8e-05	CbGpPWpGaD
Estrone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.41e-06	9.78e-05	CbGpPWpGaD
Estrone—SLCO1B1—Metabolism—NCOR1—urinary bladder cancer	4.39e-06	9.72e-05	CbGpPWpGaD
Estrone—SLCO1B1—Metabolism—GSTM1—urinary bladder cancer	4.39e-06	9.72e-05	CbGpPWpGaD
Estrone—ALB—Metabolism—RRM2—urinary bladder cancer	4.38e-06	9.71e-05	CbGpPWpGaD
Estrone—ESR2—Gene Expression—MYC—urinary bladder cancer	4.33e-06	9.59e-05	CbGpPWpGaD
Estrone—CYP1A1—Metabolism—GSTT1—urinary bladder cancer	4.32e-06	9.57e-05	CbGpPWpGaD
Estrone—CYP1B1—Metabolism—GPX1—urinary bladder cancer	4.28e-06	9.48e-05	CbGpPWpGaD
Estrone—ALB—Hemostasis—CREBBP—urinary bladder cancer	4.26e-06	9.43e-05	CbGpPWpGaD
Estrone—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.25e-06	9.42e-05	CbGpPWpGaD
Estrone—ALB—Hemostasis—IGF1—urinary bladder cancer	4.2e-06	9.32e-05	CbGpPWpGaD
Estrone—SLCO1B1—Metabolism—GPX1—urinary bladder cancer	4.2e-06	9.31e-05	CbGpPWpGaD
Estrone—CYP1B1—Metabolism—ERCC2—urinary bladder cancer	4.2e-06	9.31e-05	CbGpPWpGaD
Estrone—CYP2C9—Metabolism—NAT2—urinary bladder cancer	4.15e-06	9.21e-05	CbGpPWpGaD
Estrone—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	4.12e-06	9.14e-05	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	4.12e-06	9.13e-05	CbGpPWpGaD
Estrone—ABCG2—Metabolism—TYMS—urinary bladder cancer	4.11e-06	9.11e-05	CbGpPWpGaD
Estrone—ABCG2—Metabolism—GSTM1—urinary bladder cancer	4.06e-06	9e-05	CbGpPWpGaD
Estrone—ABCG2—Metabolism—NCOR1—urinary bladder cancer	4.06e-06	9e-05	CbGpPWpGaD
Estrone—ALB—Metabolism—ENO2—urinary bladder cancer	4.06e-06	8.99e-05	CbGpPWpGaD
Estrone—ALB—Metabolism—HPGDS—urinary bladder cancer	4.06e-06	8.99e-05	CbGpPWpGaD
Estrone—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.03e-06	8.94e-05	CbGpPWpGaD
Estrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	3.96e-06	8.78e-05	CbGpPWpGaD
Estrone—CYP1B1—Metabolism—MTHFR—urinary bladder cancer	3.95e-06	8.75e-05	CbGpPWpGaD
Estrone—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.94e-06	8.73e-05	CbGpPWpGaD
Estrone—ALB—Metabolism—GSTT1—urinary bladder cancer	3.93e-06	8.72e-05	CbGpPWpGaD
Estrone—CYP1A2—Metabolism—TYMP—urinary bladder cancer	3.92e-06	8.7e-05	CbGpPWpGaD
Estrone—CYP4A11—Metabolism—PTGS2—urinary bladder cancer	3.91e-06	8.66e-05	CbGpPWpGaD
Estrone—ABCG2—Metabolism—GPX1—urinary bladder cancer	3.89e-06	8.62e-05	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	3.89e-06	8.62e-05	CbGpPWpGaD
Estrone—CYP2B6—Metabolism—NQO1—urinary bladder cancer	3.88e-06	8.61e-05	CbGpPWpGaD
Estrone—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	3.88e-06	8.59e-05	CbGpPWpGaD
Estrone—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.87e-06	8.59e-05	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—S100B—urinary bladder cancer	3.86e-06	8.56e-05	CbGpPWpGaD
Estrone—ALB—Hemostasis—RHOA—urinary bladder cancer	3.85e-06	8.54e-05	CbGpPWpGaD
Estrone—ABCB1—Metabolism—RRM2—urinary bladder cancer	3.84e-06	8.51e-05	CbGpPWpGaD
Estrone—ESR1—Gene Expression—PPARG—urinary bladder cancer	3.83e-06	8.48e-05	CbGpPWpGaD
Estrone—ABCG2—Metabolism—ERCC2—urinary bladder cancer	3.82e-06	8.47e-05	CbGpPWpGaD
Estrone—CYP2E1—Metabolism—NQO1—urinary bladder cancer	3.8e-06	8.43e-05	CbGpPWpGaD
Estrone—CYP3A5—Metabolism—NQO1—urinary bladder cancer	3.8e-06	8.42e-05	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	3.79e-06	8.4e-05	CbGpPWpGaD
Estrone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.77e-06	8.36e-05	CbGpPWpGaD
Estrone—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.68e-06	8.17e-05	CbGpPWpGaD
Estrone—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	3.68e-06	8.15e-05	CbGpPWpGaD
Estrone—ESR1—Gene Expression—CREBBP—urinary bladder cancer	3.67e-06	8.15e-05	CbGpPWpGaD
Estrone—ABCG2—Metabolism—MTHFR—urinary bladder cancer	3.59e-06	7.96e-05	CbGpPWpGaD
Estrone—CYP1A1—Metabolism—NQO1—urinary bladder cancer	3.59e-06	7.95e-05	CbGpPWpGaD
Estrone—CYP2C9—Metabolism—RRM2—urinary bladder cancer	3.59e-06	7.95e-05	CbGpPWpGaD
Estrone—ABCB1—Metabolism—HPGDS—urinary bladder cancer	3.55e-06	7.88e-05	CbGpPWpGaD
Estrone—ABCB1—Metabolism—ENO2—urinary bladder cancer	3.55e-06	7.88e-05	CbGpPWpGaD
Estrone—CYP1A2—Metabolism—NAT2—urinary bladder cancer	3.55e-06	7.87e-05	CbGpPWpGaD
Estrone—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	3.53e-06	7.83e-05	CbGpPWpGaD
Estrone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.48e-06	7.72e-05	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—NCOR1—urinary bladder cancer	3.47e-06	7.69e-05	CbGpPWpGaD
Estrone—ABCB1—Metabolism—GSTT1—urinary bladder cancer	3.45e-06	7.64e-05	CbGpPWpGaD
Estrone—CYP4A11—Metabolism—PTEN—urinary bladder cancer	3.41e-06	7.55e-05	CbGpPWpGaD
Estrone—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	3.32e-06	7.36e-05	CbGpPWpGaD
Estrone—CYP2C9—Metabolism—ENO2—urinary bladder cancer	3.32e-06	7.36e-05	CbGpPWpGaD
Estrone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.3e-06	7.32e-05	CbGpPWpGaD
Estrone—ALB—Metabolism—NQO1—urinary bladder cancer	3.27e-06	7.25e-05	CbGpPWpGaD
Estrone—CYP4A11—Metabolism—EP300—urinary bladder cancer	3.25e-06	7.2e-05	CbGpPWpGaD
Estrone—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	3.24e-06	7.18e-05	CbGpPWpGaD
Estrone—ALB—Hemostasis—IL2—urinary bladder cancer	3.23e-06	7.16e-05	CbGpPWpGaD
Estrone—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.23e-06	7.16e-05	CbGpPWpGaD
Estrone—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	3.22e-06	7.14e-05	CbGpPWpGaD
Estrone—CYP1B1—Metabolism—PPARG—urinary bladder cancer	3.2e-06	7.09e-05	CbGpPWpGaD
Estrone—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	3.17e-06	7.04e-05	CbGpPWpGaD
Estrone—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.17e-06	7.03e-05	CbGpPWpGaD
Estrone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.17e-06	7.03e-05	CbGpPWpGaD
Estrone—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	3.17e-06	7.02e-05	CbGpPWpGaD
Estrone—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	3.14e-06	6.97e-05	CbGpPWpGaD
Estrone—CYP1B1—Metabolism—CREBBP—urinary bladder cancer	3.07e-06	6.81e-05	CbGpPWpGaD
Estrone—CYP1A2—Metabolism—RRM2—urinary bladder cancer	3.06e-06	6.79e-05	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—TERT—urinary bladder cancer	3.06e-06	6.78e-05	CbGpPWpGaD
Estrone—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.04e-06	6.73e-05	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.03e-06	6.72e-05	CbGpPWpGaD
Estrone—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	3.02e-06	6.69e-05	CbGpPWpGaD
Estrone—CYP2B6—Metabolism—TYMS—urinary bladder cancer	3.01e-06	6.68e-05	CbGpPWpGaD
Estrone—CYP1A1—Metabolism—GSTP1—urinary bladder cancer	2.99e-06	6.63e-05	CbGpPWpGaD
Estrone—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	2.98e-06	6.6e-05	CbGpPWpGaD
Estrone—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	2.98e-06	6.6e-05	CbGpPWpGaD
Estrone—CYP2E1—Metabolism—TYMS—urinary bladder cancer	2.95e-06	6.54e-05	CbGpPWpGaD
Estrone—CYP3A5—Metabolism—TYMS—urinary bladder cancer	2.94e-06	6.53e-05	CbGpPWpGaD
Estrone—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	2.92e-06	6.46e-05	CbGpPWpGaD
Estrone—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	2.92e-06	6.46e-05	CbGpPWpGaD
Estrone—ABCG2—Metabolism—PPARG—urinary bladder cancer	2.91e-06	6.45e-05	CbGpPWpGaD
Estrone—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	2.91e-06	6.45e-05	CbGpPWpGaD
Estrone—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	2.91e-06	6.45e-05	CbGpPWpGaD
Estrone—ALB—Hemostasis—EP300—urinary bladder cancer	2.9e-06	6.43e-05	CbGpPWpGaD
Estrone—CYP1A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.89e-06	6.42e-05	CbGpPWpGaD
Estrone—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	2.89e-06	6.41e-05	CbGpPWpGaD
Estrone—ABCB1—Metabolism—NQO1—urinary bladder cancer	2.87e-06	6.35e-05	CbGpPWpGaD
Estrone—CYP2B6—Metabolism—GPX1—urinary bladder cancer	2.85e-06	6.32e-05	CbGpPWpGaD
Estrone—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	2.84e-06	6.29e-05	CbGpPWpGaD
Estrone—CYP1A2—Metabolism—ENO2—urinary bladder cancer	2.84e-06	6.29e-05	CbGpPWpGaD
Estrone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.82e-06	6.25e-05	CbGpPWpGaD
Estrone—ALB—Hemostasis—SRC—urinary bladder cancer	2.82e-06	6.25e-05	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—FGFR3—urinary bladder cancer	2.81e-06	6.22e-05	CbGpPWpGaD
Estrone—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	2.8e-06	6.21e-05	CbGpPWpGaD
Estrone—ABCG2—Metabolism—CREBBP—urinary bladder cancer	2.8e-06	6.2e-05	CbGpPWpGaD
Estrone—CYP2E1—Metabolism—GPX1—urinary bladder cancer	2.79e-06	6.19e-05	CbGpPWpGaD
Estrone—CYP3A5—Metabolism—GPX1—urinary bladder cancer	2.79e-06	6.18e-05	CbGpPWpGaD
Estrone—CYP1A1—Metabolism—TYMS—urinary bladder cancer	2.78e-06	6.17e-05	CbGpPWpGaD
Estrone—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.77e-06	6.13e-05	CbGpPWpGaD
Estrone—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	2.75e-06	6.1e-05	CbGpPWpGaD
Estrone—CYP1A1—Metabolism—GSTM1—urinary bladder cancer	2.75e-06	6.1e-05	CbGpPWpGaD
Estrone—CYP1A1—Metabolism—NCOR1—urinary bladder cancer	2.75e-06	6.1e-05	CbGpPWpGaD
Estrone—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	2.74e-06	6.08e-05	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.74e-06	6.07e-05	CbGpPWpGaD
Estrone—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	2.74e-06	6.07e-05	CbGpPWpGaD
Estrone—ALB—Metabolism—GSTP1—urinary bladder cancer	2.73e-06	6.05e-05	CbGpPWpGaD
Estrone—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.71e-06	6.01e-05	CbGpPWpGaD
Estrone—CYP2C9—Metabolism—NQO1—urinary bladder cancer	2.68e-06	5.93e-05	CbGpPWpGaD
Estrone—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.64e-06	5.85e-05	CbGpPWpGaD
Estrone—CYP1A1—Metabolism—GPX1—urinary bladder cancer	2.63e-06	5.84e-05	CbGpPWpGaD
Estrone—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	2.63e-06	5.83e-05	CbGpPWpGaD
Estrone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.6e-06	5.76e-05	CbGpPWpGaD
Estrone—CYP1A1—Metabolism—ERCC2—urinary bladder cancer	2.59e-06	5.73e-05	CbGpPWpGaD
Estrone—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	2.58e-06	5.71e-05	CbGpPWpGaD
Estrone—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	2.57e-06	5.7e-05	CbGpPWpGaD
Estrone—ALB—Metabolism—TYMS—urinary bladder cancer	2.54e-06	5.62e-05	CbGpPWpGaD
Estrone—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	2.52e-06	5.59e-05	CbGpPWpGaD
Estrone—CYP1B1—Metabolism—PTGS2—urinary bladder cancer	2.52e-06	5.58e-05	CbGpPWpGaD
Estrone—ALB—Metabolism—NCOR1—urinary bladder cancer	2.51e-06	5.56e-05	CbGpPWpGaD
Estrone—ALB—Metabolism—GSTM1—urinary bladder cancer	2.51e-06	5.56e-05	CbGpPWpGaD
Estrone—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	2.47e-06	5.48e-05	CbGpPWpGaD
Estrone—CYP1A1—Metabolism—MTHFR—urinary bladder cancer	2.43e-06	5.39e-05	CbGpPWpGaD
Estrone—SLCO1A2—Metabolism—EP300—urinary bladder cancer	2.41e-06	5.33e-05	CbGpPWpGaD
Estrone—ALB—Metabolism—GPX1—urinary bladder cancer	2.4e-06	5.32e-05	CbGpPWpGaD
Estrone—ABCB1—Metabolism—GSTP1—urinary bladder cancer	2.39e-06	5.3e-05	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—CREBBP—urinary bladder cancer	2.39e-06	5.3e-05	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.36e-06	5.24e-05	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—IGF1—urinary bladder cancer	2.36e-06	5.23e-05	CbGpPWpGaD
Estrone—ALB—Metabolism—ERCC2—urinary bladder cancer	2.36e-06	5.22e-05	CbGpPWpGaD
Estrone—ALB—Hemostasis—KRAS—urinary bladder cancer	2.33e-06	5.17e-05	CbGpPWpGaD
Estrone—ABCG2—Metabolism—PTGS2—urinary bladder cancer	2.29e-06	5.08e-05	CbGpPWpGaD
Estrone—CYP1A2—Metabolism—NQO1—urinary bladder cancer	2.29e-06	5.07e-05	CbGpPWpGaD
Estrone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.26e-06	5.02e-05	CbGpPWpGaD
Estrone—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	2.23e-06	4.95e-05	CbGpPWpGaD
Estrone—ABCB1—Metabolism—TYMS—urinary bladder cancer	2.22e-06	4.93e-05	CbGpPWpGaD
Estrone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.22e-06	4.92e-05	CbGpPWpGaD
Estrone—ALB—Metabolism—MTHFR—urinary bladder cancer	2.22e-06	4.91e-05	CbGpPWpGaD
Estrone—ABCB1—Metabolism—NCOR1—urinary bladder cancer	2.2e-06	4.87e-05	CbGpPWpGaD
Estrone—ABCB1—Metabolism—GSTM1—urinary bladder cancer	2.2e-06	4.87e-05	CbGpPWpGaD
Estrone—CYP1B1—Metabolism—PTEN—urinary bladder cancer	2.2e-06	4.87e-05	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.19e-06	4.85e-05	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.19e-06	4.85e-05	CbGpPWpGaD
Estrone—ESR1—Gene Expression—MYC—urinary bladder cancer	2.18e-06	4.83e-05	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—RHOA—urinary bladder cancer	2.16e-06	4.79e-05	CbGpPWpGaD
Estrone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.16e-06	4.79e-05	CbGpPWpGaD
Estrone—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	2.16e-06	4.78e-05	CbGpPWpGaD
Estrone—CYP2B6—Metabolism—PPARG—urinary bladder cancer	2.13e-06	4.73e-05	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.12e-06	4.71e-05	CbGpPWpGaD
Estrone—ABCB1—Metabolism—GPX1—urinary bladder cancer	2.1e-06	4.66e-05	CbGpPWpGaD
Estrone—CYP1B1—Metabolism—EP300—urinary bladder cancer	2.09e-06	4.64e-05	CbGpPWpGaD
Estrone—CYP2E1—Metabolism—PPARG—urinary bladder cancer	2.09e-06	4.63e-05	CbGpPWpGaD
Estrone—CYP3A5—Metabolism—PPARG—urinary bladder cancer	2.09e-06	4.62e-05	CbGpPWpGaD
Estrone—CYP2C9—Metabolism—TYMS—urinary bladder cancer	2.08e-06	4.6e-05	CbGpPWpGaD
Estrone—ALB—Hemostasis—TP53—urinary bladder cancer	2.07e-06	4.6e-05	CbGpPWpGaD
Estrone—ABCB1—Metabolism—ERCC2—urinary bladder cancer	2.06e-06	4.58e-05	CbGpPWpGaD
Estrone—SLCO1B1—Metabolism—EP300—urinary bladder cancer	2.06e-06	4.56e-05	CbGpPWpGaD
Estrone—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	2.05e-06	4.55e-05	CbGpPWpGaD
Estrone—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	2.05e-06	4.55e-05	CbGpPWpGaD
Estrone—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	2.05e-06	4.54e-05	CbGpPWpGaD
Estrone—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	2.01e-06	4.45e-05	CbGpPWpGaD
Estrone—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	2e-06	4.44e-05	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—ERBB2—urinary bladder cancer	2e-06	4.44e-05	CbGpPWpGaD
Estrone—ABCG2—Metabolism—PTEN—urinary bladder cancer	2e-06	4.43e-05	CbGpPWpGaD
Estrone—ALB—Hemostasis—HRAS—urinary bladder cancer	1.98e-06	4.4e-05	CbGpPWpGaD
Estrone—CYP1A1—Metabolism—PPARG—urinary bladder cancer	1.97e-06	4.37e-05	CbGpPWpGaD
Estrone—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.96e-06	4.36e-05	CbGpPWpGaD
Estrone—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.94e-06	4.3e-05	CbGpPWpGaD
Estrone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.94e-06	4.29e-05	CbGpPWpGaD
Estrone—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.93e-06	4.28e-05	CbGpPWpGaD
Estrone—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.91e-06	4.23e-05	CbGpPWpGaD
Estrone—ABCG2—Metabolism—EP300—urinary bladder cancer	1.9e-06	4.22e-05	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—CXCL8—urinary bladder cancer	1.9e-06	4.21e-05	CbGpPWpGaD
Estrone—CYP1A1—Metabolism—CREBBP—urinary bladder cancer	1.89e-06	4.2e-05	CbGpPWpGaD
Estrone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.85e-06	4.09e-05	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—IL2—urinary bladder cancer	1.81e-06	4.02e-05	CbGpPWpGaD
Estrone—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.81e-06	4.02e-05	CbGpPWpGaD
Estrone—ALB—Metabolism—PPARG—urinary bladder cancer	1.8e-06	3.98e-05	CbGpPWpGaD
Estrone—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.77e-06	3.93e-05	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—CCND1—urinary bladder cancer	1.77e-06	3.92e-05	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.77e-06	3.91e-05	CbGpPWpGaD
Estrone—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.75e-06	3.89e-05	CbGpPWpGaD
Estrone—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.75e-06	3.89e-05	CbGpPWpGaD
Estrone—ALB—Metabolism—CREBBP—urinary bladder cancer	1.73e-06	3.83e-05	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—MMP9—urinary bladder cancer	1.72e-06	3.8e-05	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.71e-06	3.79e-05	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—PTEN—urinary bladder cancer	1.71e-06	3.78e-05	CbGpPWpGaD
Estrone—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.68e-06	3.72e-05	CbGpPWpGaD
Estrone—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	1.68e-06	3.72e-05	CbGpPWpGaD
Estrone—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.65e-06	3.65e-05	CbGpPWpGaD
Estrone—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	1.64e-06	3.64e-05	CbGpPWpGaD
Estrone—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	1.64e-06	3.64e-05	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—EP300—urinary bladder cancer	1.63e-06	3.61e-05	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—SRC—urinary bladder cancer	1.58e-06	3.51e-05	CbGpPWpGaD
Estrone—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.57e-06	3.49e-05	CbGpPWpGaD
Estrone—CYP1A1—Metabolism—PTGS2—urinary bladder cancer	1.55e-06	3.44e-05	CbGpPWpGaD
Estrone—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.55e-06	3.43e-05	CbGpPWpGaD
Estrone—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.51e-06	3.35e-05	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.47e-06	3.26e-05	CbGpPWpGaD
Estrone—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.47e-06	3.26e-05	CbGpPWpGaD
Estrone—CYP2B6—Metabolism—PTEN—urinary bladder cancer	1.46e-06	3.25e-05	CbGpPWpGaD
Estrone—CYP2E1—Metabolism—PTEN—urinary bladder cancer	1.43e-06	3.18e-05	CbGpPWpGaD
Estrone—CYP3A5—Metabolism—PTEN—urinary bladder cancer	1.43e-06	3.17e-05	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—MYC—urinary bladder cancer	1.42e-06	3.14e-05	CbGpPWpGaD
Estrone—ALB—Metabolism—PTGS2—urinary bladder cancer	1.41e-06	3.13e-05	CbGpPWpGaD
Estrone—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.41e-06	3.13e-05	CbGpPWpGaD
Estrone—CYP2B6—Metabolism—EP300—urinary bladder cancer	1.4e-06	3.09e-05	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—EGFR—urinary bladder cancer	1.39e-06	3.07e-05	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.37e-06	3.03e-05	CbGpPWpGaD
Estrone—CYP2E1—Metabolism—EP300—urinary bladder cancer	1.37e-06	3.03e-05	CbGpPWpGaD
Estrone—CYP3A5—Metabolism—EP300—urinary bladder cancer	1.36e-06	3.02e-05	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.35e-06	3e-05	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.35e-06	3e-05	CbGpPWpGaD
Estrone—CYP1A1—Metabolism—PTEN—urinary bladder cancer	1.35e-06	3e-05	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—KRAS—urinary bladder cancer	1.31e-06	2.9e-05	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.3e-06	2.87e-05	CbGpPWpGaD
Estrone—CYP1A1—Metabolism—EP300—urinary bladder cancer	1.29e-06	2.86e-05	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.27e-06	2.82e-05	CbGpPWpGaD
Estrone—CYP1A2—Metabolism—PPARG—urinary bladder cancer	1.26e-06	2.79e-05	CbGpPWpGaD
Estrone—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.24e-06	2.74e-05	CbGpPWpGaD
Estrone—ALB—Metabolism—PTEN—urinary bladder cancer	1.23e-06	2.73e-05	CbGpPWpGaD
Estrone—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	1.21e-06	2.68e-05	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.2e-06	2.65e-05	CbGpPWpGaD
Estrone—ALB—Metabolism—EP300—urinary bladder cancer	1.18e-06	2.61e-05	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—TP53—urinary bladder cancer	1.16e-06	2.58e-05	CbGpPWpGaD
Estrone—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	1.16e-06	2.56e-05	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—HRAS—urinary bladder cancer	1.11e-06	2.47e-05	CbGpPWpGaD
Estrone—ABCB1—Metabolism—PTEN—urinary bladder cancer	1.08e-06	2.39e-05	CbGpPWpGaD
Estrone—ABCB1—Metabolism—EP300—urinary bladder cancer	1.03e-06	2.28e-05	CbGpPWpGaD
Estrone—CYP2C9—Metabolism—PTEN—urinary bladder cancer	1.01e-06	2.24e-05	CbGpPWpGaD
Estrone—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	9.88e-07	2.19e-05	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—PPARG—urinary bladder cancer	9.7e-07	2.15e-05	CbGpPWpGaD
Estrone—CYP2C9—Metabolism—EP300—urinary bladder cancer	9.62e-07	2.13e-05	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	9.31e-07	2.06e-05	CbGpPWpGaD
Estrone—CYP1A2—Metabolism—PTEN—urinary bladder cancer	8.62e-07	1.91e-05	CbGpPWpGaD
Estrone—CYP1A2—Metabolism—EP300—urinary bladder cancer	8.22e-07	1.82e-05	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	7.63e-07	1.69e-05	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—PTEN—urinary bladder cancer	6.65e-07	1.47e-05	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—EP300—urinary bladder cancer	6.34e-07	1.41e-05	CbGpPWpGaD
